Search - tctmd.com

Displaying 221 - 240 of 276

Sort: Relevancy | Date

Presentation

Drug-eluting Balloon for Treatment of Superficial Femoral Artery In-stent Restenosis

Presenter: E. Stabile

October 04, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

Presentation GI2 2012

Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis

Presenter: Marco V. Wainstein

April 12, 2012

Presentation GI2 2012

The Controversy: DES vs DEB for In-Stent Restenosis

Presenter: Pedro A. Lemos

April 11, 2012

Presentation GI2 2012

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Presenter: Jose Ribamar Costa

April 11, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

News Conference News ACC 2012

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

March 24, 2012

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

March 13, 2012

Presentation

Randomized Trial of Optimal Treatment Strategies for In-Stent Restenosis After DES Implantation

Presenter: H. Song

March 12, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Jason Kahn

March 06, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

Presentation

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Presenter: G. Maluenda

February 15, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

Advertisement

Drug-eluting Balloon for Treatment of Superficial Femoral Artery In-stent Restenosis

Stent Fractures Persist Among Newer-Generation Devices

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

CIBELES: Xience Stands Up to Cypher for CTO PCI

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis

The Controversy: DES vs DEB for In-Stent Restenosis

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

SES Effective for Both Focal, Diffuse DES Restenosis

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

Randomized Trial of Optimal Treatment Strategies for In-Stent Restenosis After DES Implantation

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

SCAAR: Second-Generation DES Improve Hard Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content